This study is in progress, not accepting new patients
A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- AbbVie
- Links
- Related Info
- ID
- NCT00481091
- Phase
- Phase 1/2
- Study Type
- Interventional
- Last Updated